The expression of the UBR5-ZNF423 and RARS-MAD1L1 fusion genes enables NPC cells to proliferate and form colonies in vitro and induce tumorigenesis in vivo [37,38]. The gene discussed is RARS1; the disease is nasopharyngeal carcinoma.